Search Results - "Alfaro, MB Marzal"

Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC project by Chamorro-de-Vega, Esther, Rodriguez-Gonzalez, Carmen Guadalupe, Gimenez-Manzorro, Alvaro, de Lorenzo-Pinto, Ana, Iglesias-Peinado, Irene, Herranz, Ana, Sanjurjo, Maria

“…Pharmaceutical care is needed in hepatitis C virus (HCV)-infected patients treated with direct-acting antivirals (DAA). We describe the implementation of a…”
Get more information

PP-037 Risk of microbial contamination of pharmacy sterile preparations: A risk based decision matrix by Navarro, C Ortega, López, MS Pernia, Revuelta, JL, Pozo, M Tovar, Martínez, C Ruiz, García, B Monje, Alfaro, MB Marzal, Jiménez, RM Romero, Alonso, A Herranz, Sáez, M Sanjurjo

“…BackgroundIn order to adapt Spanish regulations to the principles set out in the European Resolution CM/ResAP(2011)1 on quality and safety assurance…”
Get full text

4CPS-127 Development of a stratification model for ambulatory oncology pharmacy patients by Revuelta Herrero, JL, Marzal-Alfaro, MB, Escudero-Vilaplana, V, Collado-Borrell, R, de Lorenzo-Pinto, A, González Haba-Peña, E, García-Sánchez, R, Sánchez-Fresneda, MN, Herranz-Alonso, A, Sanjurjo-Saéz, M

“…BackgroundTo our knowledge, there is no pharmacy stratification model for patients in the oncology ambulatory setting.PurposeTo develop a tool to stratify…”
Get full text